InsidersTradesSigma
Oryzon Genomics SA Stock: price and management transactions · Spain · CNMV
Follow the Oryzon Genomics SA stock price and the full management transaction log of the company, a listed equity based in Spain. Shares are quoted on ES ES, under the supervision of CNMV. Operating in the Health Care sector, Oryzon Genomics SA has recorded 0 reports. Market capitalisation: €244.7m. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations
About Oryzon Genomics SA
Oryzon Genomics SA is a biopharmaceutical company focused on developing innovative therapies for the treatment of neurodegenerative diseases and cancers. It is listed on the XMAD market.